AIA Group Ltd raised its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 20.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,983 shares of the healthcare conglomerate’s stock after buying an additional 4,106 shares during the period. AIA Group Ltd’s holdings in UnitedHealth Group were worth $12,132,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $25,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $30,000. Promus Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $32,000. Pillar Financial Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth about $40,000. Finally, DecisionPoint Financial LLC increased its stake in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.
Wall Street Analyst Weigh In
UNH has been the subject of a number of research analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Oppenheimer raised their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Finally, Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $629.32.
UnitedHealth Group Trading Down 0.0 %
Shares of UNH stock opened at $515.47 on Monday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average is $508.81 and its two-hundred day moving average is $543.92. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a market capitalization of $471.51 billion, a P/E ratio of 33.26, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.83 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.63%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.33% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Earnings Per Share Calculator: How to Calculate EPS
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- MarketBeat Week in Review – 03/24 – 03/28
- There Are Different Types of Stock To Invest In
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.